These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6875837)

  • 1. NMR studies and GC analysis of the antibacterial agent taurolidine.
    Knight BI; Skellern GG; Smail GA; Browne MK; Pfirrmann RW
    J Pharm Sci; 1983 Jun; 72(6):705-7. PubMed ID: 6875837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of taurolidine decomposition in polymer solutions by chromotropic acid formaldehyde assay method.
    Sihn YS; Guillory JK; Kirsch LE
    J Pharm Biomed Anal; 1997 Dec; 16(4):643-50. PubMed ID: 9502160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of polyvinylpyrrolidine on the stability of taurolidine.
    Kirsch LE; Sihn YS
    Pharm Dev Technol; 1997 Nov; 2(4):345-56. PubMed ID: 9552463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mode of antibacterial action of some 'masked' formaldehyde compounds.
    Gidley MJ; Sanders JK; Myers ER; Allwood MC
    FEBS Lett; 1981 May; 127(2):225-7. PubMed ID: 7016592
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
    Luther MK; Mermel LA; LaPlante KL
    J Antimicrob Chemother; 2014 Dec; 69(12):3263-7. PubMed ID: 25096074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained anti-adherence activity of taurolidine (Taurolin) and noxythiolin (Noxyflex S) solutions.
    Blenkharn JI
    J Pharm Pharmacol; 1988 Jul; 40(7):509-11. PubMed ID: 2904994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taurolidine susceptibility of methicillin-resistant Staphylococcus pseudintermedius isolates.
    Wormhoudt T; Séguin B; Bemis DA; Hyatt D
    J Vet Diagn Invest; 2017 Nov; 29(6):910-911. PubMed ID: 28754087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual functionality of the antimicrobial agent taurolidine which demonstrates effective anti-tumor properties in pediatric neuroblastoma.
    Swift L; Zhang C; Kovalchuk O; Boklan J; Trippett T; Narendran A
    Invest New Drugs; 2020 Jun; 38(3):690-699. PubMed ID: 31264069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
    Oguz H; Ozbilge H; Oguz E; Gurkan T
    Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients.
    Koldehoff M; Zakrzewski JL
    Int J Antimicrob Agents; 2004 Nov; 24(5):491-5. PubMed ID: 15519483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
    Betjes MG; van Agteren M
    Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taurolidine, an antilipopolysaccharide agent, has immunoregulatory properties that are mediated by the amino acid taurine.
    Watson RW; Redmond HP; Mc Carthy J; Bouchier-Hayes D
    J Leukoc Biol; 1995 Sep; 58(3):299-306. PubMed ID: 7665985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taurolidine inhibits tumour necrosis factor (TNF) toxicity--new evidence of TNF and endotoxin synergy.
    Monson JR; Ramsey PS; Donohue JH
    Eur J Surg Oncol; 1993 Jun; 19(3):226-31. PubMed ID: 8314379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
    Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of taurolidine on single species and a multispecies population associated with periodontitis.
    Zollinger L; Schnyder S; Nietzsche S; Sculean A; Eick S
    Anaerobe; 2015 Apr; 32():18-23. PubMed ID: 25460194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines.
    Walters DK; Muff R; Langsam B; Gruber P; Born W; Fuchs B
    Invest New Drugs; 2007 Aug; 25(4):305-12. PubMed ID: 17458504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
    Trials; 2018 May; 19(1):264. PubMed ID: 29720244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
    Solomon LR; Cheesbrough JS; Ebah L; Al-Sayed T; Heap M; Millband N; Waterhouse D; Mitra S; Curry A; Saxena R; Bhat R; Schulz M; Diggle P
    Am J Kidney Dis; 2010 Jun; 55(6):1060-8. PubMed ID: 20207458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taurolidine and catheter-related bloodstream infection: a systematic review of the literature.
    Bradshaw JH; Puntis JW
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):179-86. PubMed ID: 18664870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taurolidine in Pediatric Home Parenteral Nutrition Patients.
    Hulshof EC; Hanff LM; Olieman J; de Vette S; Driessen GJ; Meeussen C; Escher JC
    Pediatr Infect Dis J; 2017 Feb; 36(2):233-235. PubMed ID: 27846059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.